Genome & Co. (314130) Price & Analysis

― Followers

314130 Stock Chart & Stats

₩4205.00

-₩210.00(-4.76%)

Aug 21, 2026

―

Day’s Range― - ―

52-Week Range₩2,440.00 - ₩10,180.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)428.53K

Market Cap

₩230.90B

Enterprise Value₩133.62K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.42

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-997.08

Shares Outstanding52,299,423

10 Day Avg. Volume297,013

30 Day Avg. Volume428,527

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

314130 FAQ

What was Genome & Co.’s price range in the past 12 months?

Genome & Co. lowest stock price was ₩2440.00 and its highest was ₩10180.00 in the past 12 months.

What is Genome & Co.’s market cap?

Genome & Co.’s market cap is ₩230.90B.

When is Genome & Co.’s upcoming earnings report date?

Genome & Co.’s upcoming earnings report date is Nov 12, 2026 which is in 81 days.

How were Genome & Co.’s earnings last quarter?

Genome & Co. released its earnings results on Aug 14, 2026. The company reported -₩997.077 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Genome & Co. overvalued?

According to Wall Street analysts Genome & Co.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Genome & Co. pay dividends?

Genome & Co. does not currently pay dividends.

What is Genome & Co.’s EPS estimate?

Genome & Co.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Genome & Co. have?

Genome & Co. has 52,299,423 shares outstanding.

What happened to Genome & Co.’s price movement after its last earnings report?

Genome & Co. reported an EPS of -₩997.077 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.587%.

Which hedge fund is a major shareholder of Genome & Co.?

Currently, no hedge funds are holding shares in KR:314130

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology